E-LIB Suche - Ergebnisse für: Arriola Aperribay, Edurne

1

Accurate Identification of ALK Positive Lung Carcinoma Pati..:

Conde, Esther ; Suárez Gauthier, Ana ; Benito, Amparo...
Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0107200. , 2014

Link: http://hdl.handle.net/24..

2

Phase III study of selpercatinib versus chemotherapy ± pemb..:

Solomon, Benjamin J ; Zhou, Cai Cun ; Drilon, Alexander...
Future Oncol. 2021;17(7):763-73. ,

Link: http://hdl.handle.net/10..

3

Immunotherapy is here to stay: a new treatment paradigm in ..:

Rocha, Pedro P ; Arriola Aperribay, Edurne
Archivos de Bronconeumología. 2019 Mar;55(3):124-5. ,

Link: http://hdl.handle.net/10..

4

Acquired mechanisms of resistance to osimertinib-the next c..:

Ríos-Hoyo, Alejandro ; Moliner Jiménez, Laura ; Arriola Aperribay, Edurne
Ríos-Hoyo A, Moliner L, Arriola E. Acquired mechanisms of resistance to osimertinib-the next challenge. Cancers (Basel). 2022 Apr 12; 14(8): 1931. DOI:10.3390/cancers14081931. ,

Link: http://hdl.handle.net/10..

5

Diffuse dermal mucinosis secondary to colony-stimulating fa..:

Olmos Alpiste, Ferran ; Segura Tigell, Sonia ; Tomás-Velázquez, Alejandra...
Olmos-Alpiste F, Segura S, Tomás-Velázquez A, Aguado L, España A, Arriola E, Martín-Algarra S, Barranco C, Lloreta J, Pujol RM. Diffuse dermal mucinosis secondary to colony-stimulating factor 1 receptor monoclonal antibody treatment: A novel and peculiar drug-induced diffuse cutaneous mucinosis. J Dermatol. 2021; 48(3):380-4. DOI:10.1111/1346-8138.15662. ,

Link: http://hdl.handle.net/10..

6

Serum cytokine levels as predictive biomarkers of benefit f..:

Hardy-Werbin, Max ; Rocha, Pedro P ; Arpí Llucià, Oriol...
Oncoimmunology. 2019;8(6):e1593810. ,

Link: http://hdl.handle.net/10..

7

ROS1 copy number alterations are frequent in non-small cell..:

Clavé Safont, Sergi ; Gimeno Beltran, Javier ; Muñoz-Mármol, Ana M...
Oncotarget. 2016 Feb 16;7(7):8019-28. ,

Link: http://hdl.handle.net/10..

8

Prognostic value of clinical staging according to TNM in pa..:

Arriola Aperribay, Edurne ; Trigo i Rodríguez, Josep M ; Sánchez-Gastaldo, Amparo...
JTO Clin Res Rep. 2021 Dec 10;3(1):100266. ,

Link: http://hdl.handle.net/10..

9

CD33 expression on peripheral blood monocytes predicts effi..:

Olingy, Claire ; Alimadadi, Ahmad ; Araujo, Daniel J...
Olingy C, Alimadadi A, Araujo DJ, Barry D, Gutierrez NA, Werbin MH, et al. CD33 expression on peripheral blood monocytes predicts efficacy of anti-PD-1 immunotherapy against non-small cell lung cancer. Front Immunol. 2022 Apr 14; 13: 842653. DOI:10.3389/fimmu.2022.842653. ,

Link: http://hdl.handle.net/10..

10

EGFR and KRAS mutations in the non-tumoral lung. Prognosis ..:

Chalela Rengifo, Roberto José, 1985- ; Bellosillo Paricio, Beatriz ; Curull Serrano, Víctor...
Journal of Clinical Medicine. 2019 Apr 17;8(4):529. ,

Link: http://hdl.handle.net/10..

11

Comparison of different methods for defining hyperprogressi..:

Rocha, Pedro P ; Ramal, Didac ; Ripoll, Enric...
Comparison of different methods for defining hyperprogressive disease in NSCLC. JTO Clin Res Rep. 2020 Oct 28; 2(1): 100115. DOI:10.1016/j.jtocrr.2020.100115. ,

Link: http://hdl.handle.net/10..

12

Healthcare resource utilization in advanced non-small-cell ..:

Garon, Edward B ; Winfree, Katherine B ; Molife, Cliff...
Garon EB, Winfree KB, Molife C, Cui ZL, Arriola E, Levy B, et al. Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study. Support Care Cancer. 2021 Jan;29(1):117-25. DOI:10.1007/s00520-020-05459-0. ,

Link: http://hdl.handle.net/10..

13

CD8 T-cell-mediated cerebellitis directed against Purkinje ..:

Hardwick, Marc ; Nolan, Luke ; Nicoll, James A.R...
Hardwick M, Nolan L, Nicoll JAR, Jogai S, Arriola E, Joseph-Pietras D, et al. CD8 T-cell-mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer. Neuropathol Appl Neurobiol. 2022 Feb; 48(2): e12755. DOI:10.1111/nan.12755. ,

Link: http://hdl.handle.net/10..

14

Is there a role for epidermal growth factor receptor tyrosi..:

Arriola Aperribay, Edurne ; Taus García, Álvaro ; Casadevall Aguilar, David
World Journal of Clinical Oncology. 2015 Aug 10;6(4):45-56. ,

Link: http://hdl.handle.net/10..

15

Addition of immune checkpoint inhibitors to chemotherapy vs..:

Arriola Aperribay, Edurne ; González-Cao, María ; Domine, Manuel...
Oncol Ther. 2022 Jun;10(1):167-84. ,

Link: http://hdl.handle.net/10..